WithdrawnPhase 3

Use of Tranexamic Acid in Blepharoplasties

Stopped: Stopped study due to pharmacy issues before treating patients

United States0Started 2020-02-20

Plain-language summary

The goal of this investigation is to assess whether or not there is a significant difference in the presence and/or degree of post-operative ecchymosis, pain, and edema between groups of patients undergoing upper lid blepharoplasty with traditional local anesthetic (LA) and those who receive tranexamic acid (TXA) in addition to traditional LA.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * any adult patient who is undergoing upper lid blepharoplasty with author Douglas Sidle, MD and who is older than 18 years of age, fluent in English, not on any anticoagulant or antiplatelet medication (e.g. aspirin, clopidogrel, etc.), not diagnosed with a coagulation disorder, not pregnant, not undergoing a simultaneous procedure, and not a Feinberg School of Medicine (FSM) student or Northwestern Memorial (NM) employee. Exclusion Criteria: * less than 18 years of age, not fluent in English, taking anticoagulant or antiplatelet, has coagulation disorder, pregnant, simultaneous procedure, FSM or NM student/employee

What they're measuring

change in bruising

Timeframe: Surveys will be completed by patients at 1 week, 1 month, 3 months post-operatively

change in bruising a survey to rate pain

Timeframe: Surveys will be completed by patients at 1 week, 1 month, 3 months post-operatively

Trial details

NCT IDNCT04724772

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-20

View on ClinicalTrials.gov More Pain, Postoperative trials